Psychiatry and Neurology, Neurology · Lexington, KY
NPI
1295837094
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
1207 S Broadway
Lexington, KY, 40504
Phone (859) 258-4800
Groups this clinician bills Medicare through
Medicare paid, 2024
$62K
819 services
Medicare patients, 2024
410
Average age 74
Drug cost, 2024
$2.3M
5,264 prescriptions
Company payments, 2025
$229
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David M Blake was code 99213 (office e&m - established), 354 times for 261 patients. In total David M Blake billed 819 services in 18 codes, and Medicare paid $62K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 354 | 261 | $57.29 | $20K |
| 99214 Office E&M - Established | Office | 230 | 174 | $83.57 | $19K |
| 95886 Electrical Nerve Conductivity | Office | 61 | 54 | $64.13 | $3,912 |
| 99215 Office E&M - Established | Office | 55 | 43 | $121.53 | $6,684 |
| 99204 Office E&M - New | Office | 26 | 26 | $92.61 | $2,408 |
| 95910 Electrical Nerve Conductivity | Office | 25 | 25 | $124.69 | $3,117 |
| 95912 Electrical Nerve Conductivity | Office | 13 | 13 | $172.66 | $2,245 |
| 99212 Office E&M - Established | Office | 11 | 11 | $37.72 | $415 |
| 95909 Electrical Nerve Conductivity | Office | 11 | 11 | $62.17 | $684 |
By year: 2022 $82K for 972 services; 2023 $79K for 956 services; 2024 $62K for 819 services.
Medicare prescription drug claims, 2024
In 2024, the drug David M Blake prescribed most often to Medicare patients was Gabapentin, with 437 prescriptions and refills. In total David M Blake wrote 5,264 Medicare prescriptions that cost $2.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Gabapentin Generic | 437 | 833 | 130 | $8,335 |
| Memantine Hcl Generic | 414 | 777 | 102 | $8,631 |
| Carbidopa-Levodopa Carbidopa/Levodopa | 343 | 792 | 90 | $12K |
| Primidone Generic | 242 | 507 | 58 | $7,045 |
| Donepezil Hcl Generic | 192 | 387 | 51 | $1,621 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 176 | 351 | 44 | $4,464 |
| Levetiracetam Generic | 157 | 386 | 43 | $4,700 |
| Tramadol Hcl Generic | 155 | 171 | 35 | $1,366 |
| Alprazolam Generic | 124 | 166 | 37 | $793 |
| Baclofen Generic | 122 | 245 | 32 | $2,572 |
| Lamotrigine Generic | 98 | 184 | 19 | $1,128 |
| Butalbital-Acetaminophen-Caffe Butalb/Acetaminophen/Caffeine | 95 | 100 | 16 | $1,689 |
| Duloxetine Hcl Generic | 84 | 176 | 22 | $1,798 |
| Pregabalin Generic | 83 | 180 | 23 | $3,881 |
| Glatopa Glatiramer Acetate | 83 | 83 | Under 11 | $238K |
Brand drugs: 454 claims; generic drugs: 4,787 claims; opioid claims: 162.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David M Blake $229 ($229 in general payments such as food, travel and fees) from 3 companies. The largest payer was Takeda Pharmaceuticals U.S.A., Inc. with $125.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.